Consultancy – Training – Review
Innere Medizin – Klinische Pharmakologie
Internal Medicine – Clinical Pharmacology
Zur Person
35 Jahre Klinische Forschung

Dr. med. Matthias Klüglich
- Facharzt für Innere Medizin
- Facharzt für Klinische Pharmakologie
Curriculum vitae
Dr. med. Matthias Klüglich ist promovierter Humanmediziner und Internist, seit 2003 ist er zudem klinischer Pharmakologe. Nach seiner Klinikzeit an der Poliklinik der Ludwig-Maximilian-Universität und am Rotkreuzkrankenhaus München ging er als Projektleiter Pharmakovigilanz zur damaligen Firma Hoechst. Seit dem Jahr 2000 war er in verschiedenen Positionen bei Boehringer Ingelheim tätig, u. a. als Studienleiter Humanpharmakologie, Projektleiter F&E, Leiter der Klinischen Entwicklung von Ofev®, Abteilungsleiter Klinische Forschung (Deutschland und Frankreich) und Projektleiter Onkologie. Seit Ende 2024 ist er freiberuflich als Consultant tätig.
Consultancy
- Internistische Beratung
- Klinisch-Pharmakologische Beratung
- Strategische Fragen der Arzneimittelentwicklung
- Fortbildung zu Themen der Klinischen Forschung (z.B. ICH-GCP, CTR 536/2014, Curriculum Prüfärztetraining)
- Dokumentenreview (Klinische Entwicklung)
- Ethische Fragestellungen in Klinischen Prüfungen
Food for Thought
Drug developmentand its ethical aspects
M. Klüglich
Drug development is ethically challenging. Science can run out of control, and it can be misused. Ethics must keep pace with natural science.
Focus on medical need can resolve the antagonism between business and altruism. As long as the search for profit does not get out of hand, the road to success remains open.
The joint undertaking of multiple contributors, including the patients who participate in clinical trials, is rewarded with therapeutic progress and return on investment.
Success in developing a drug can never be guaranteed, but much can be done to
increase its likelihood. The large room to be filled with knowledge and understanding is what makes drug development so fascinating.The global innovation machine is humming. Science is confident that one day even the most challenging diseases can be treated. The chance is there if mankind works together, beats swords into ploughshares, and contains the risks associated with technological progress.

Von Target bis Launch | Matthias Klüglich, M. | ISBN: 9783871934582
Drug Development – from Target to Launch (German language)
Person
35 years of Clinical Research
Dr. med. Matthias Klüglich
- Board-certified Specialist Internal Medicine
- Board-certified Clinical Pharmacologist
Curriculum vitae
Dr. med. Matthias Klüglich is a Medical Doctor, board-certified in Internal Medicine and Clinical Pharmacology. He worked in clinical medcine at Munich University Hospital and Munich Red Cross Hospital. After joining drug development at Hoechst and later Boehringer Ingelheim, he held multiple posts, among others as Investigator in Phase 1 trials, Project Leader in R&D and Oncology, Medical Project Leader of the development of Ofev®, and Department Head of Clinical Research at Boehringer Ingelheim Germany and France. Since end of 2024, he is active as freelance Consultant in Internal Medicine and Clinical Pharmacology.
Consultancy
- Internal Medicine Consultancy
- Clinical Pharmacology Consultan
- Strategic Drug Development
- Training on ICH-GCP, CTR 536/2014 and other relevant regulations
- Review of Clinical Development reports and documents
- Considerations on Ethical Questions in Clinical Research